The trial takes place in
The Research Manager, Dr Annette Kuesel, said the new drug – Moxidectin – has the potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis or river blindness.
Source: AHU – David A-O
(Visited 1 times, 1 visits today)




Victims of onchocerciasis could soon breathe a sigh of relief as a clinical trial begins in three African countries of a drug that could eliminate the disease.